Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease
Chen, J F, Xu, K, Petzer, J P, Staal, R, Xu, Y H, Beilstein, M, Sonsalla, P K, Castagnoli, K, Castagnoli, Jr, N, Schwarzschild, M A
Published in The Journal of neuroscience (15.05.2001)
Published in The Journal of neuroscience (15.05.2001)
Get full text
Journal Article
Phase 2 Enzyme Induction by the Major Metabolite of Oltipraz
Petzer, Jacobus P, Navamal, Mettachit, Johnson, Jesse K, Kwak, Mi-Kyoung, Kensler, Thomas W, Fishbein, James C
Published in Chemical research in toxicology (01.11.2003)
Published in Chemical research in toxicology (01.11.2003)
Get full text
Journal Article
Metabolic defects caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and by HPTP (the tetrahydropyridinyl analog of haloperidol), in rats
Petzer, J P, Bergh, J J, Mienie, L J, Castagnoli, Jr, N, Van der Schyf, C J
Published in Life sciences (1973) (07.04.2000)
Published in Life sciences (1973) (07.04.2000)
Get full text
Journal Article
2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors
Legoabe, Lesetja J, Petzer, Anél, Petzer, Jacobus P
Published in Drug design, development and therapy (01.01.2015)
Published in Drug design, development and therapy (01.01.2015)
Get full text
Journal Article
3-Coumaranone derivatives as inhibitors of monoamine oxidase
Van Dyk, Adriaan S, Petzer, Jacobus P, Petzer, Anél, Legoabe, Lesetja J
Published in Drug design, development and therapy (01.01.2015)
Published in Drug design, development and therapy (01.01.2015)
Get full text
Journal Article
8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A sub(2A) Receptor Antagonism
Chen, J, Steyn, S, Staal, R, Petzer, J P, Xu, K, Van der Schyf, CJ, Castagnoli, K, Sonsalla, P K, Castagnoli Jr, N, Schwarzschild, MA
Published in The Journal of biological chemistry (27.09.2002)
Get full text
Published in The Journal of biological chemistry (27.09.2002)
Journal Article
Neuroprotection by Caffeine and A sub(2A) Adenosine Receptor Inactivation in a Model of Parkinson's Disease
Chen, Jiang-Fan, Xu, Kui, Petzer, J P, Staal, R, Xu, Yue-Hang, Beilstein, M, Sonsalla, P K, Castagnoli, K, Castagnoli, N Jr, Schwarzschild, MA
Published in The Journal of neuroscience (01.05.2001)
Get full text
Published in The Journal of neuroscience (01.05.2001)
Journal Article
Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2- c]pyridazin-5-one derivative
Ooms, Frédéric, Frédérick, Raphaël, Durant, François, Petzer, Jacobus P, Castagnoli, Neal, Van der Schyf, Cornelis J, Wouters, Johan
Published in Bioorganic & medicinal chemistry letters (06.01.2003)
Published in Bioorganic & medicinal chemistry letters (06.01.2003)
Get full text
Journal Article
Web Resource
(E)-8-(3-Chlorostyryl)-1,3,7-trimethylxanthine, a caffeine derivative acting both as antagonist of adenosine A2A receptors and as inhibitor of MAO-B
Frédérick, Raphaël, Ooms, Frederic, Castagnoli Jr, Neal, Petzer, Jacques P., Feng, Jiang-Fan, Schwarzschild, Michael A., Van der Schyf, Cornelis J., Wouters, Johan
Published in Acta crystallographica. Section C, Crystal structure communications (01.09.2005)
Published in Acta crystallographica. Section C, Crystal structure communications (01.09.2005)
Get full text
Journal Article